SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018425
Filing Date
2023-11-09
Accepted
2023-11-09 08:00:34
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230930x10q.htm   iXBRL 10-Q 1576124
2 EX-10.1 tmb-20230930xex10d1.htm EX-10.1 255540
3 EX-10.2 tmb-20230930xex10d2.htm EX-10.2 24415
4 EX-31.1 tmb-20230930xex31d1.htm EX-31.1 14524
5 EX-31.2 tmb-20230930xex31d2.htm EX-31.2 14556
6 EX-32.1 tmb-20230930xex32d1.htm EX-32.1 7203
7 EX-32.2 tmb-20230930xex32d2.htm EX-32.2 7178
  Complete submission text file 0001558370-23-018425.txt   5960619

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20230930.xsd EX-101.SCH 42990
9 EX-101.CAL tmb-20230930_cal.xml EX-101.CAL 38942
10 EX-101.DEF tmb-20230930_def.xml EX-101.DEF 164541
11 EX-101.LAB tmb-20230930_lab.xml EX-101.LAB 371953
12 EX-101.PRE tmb-20230930_pre.xml EX-101.PRE 301357
62 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230930x10q_htm.xml XML 714742
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 231390131
SIC: 2834 Pharmaceutical Preparations